One thousand patients undergoing anaesthesia in an Australian hospital were assessed by questionnaire to determine the incidence of previous anaesthesia, allergy and atopy. The patients were compared with a British group and with 85 patients who had life-threatening anaphylactoid reactions. The Australian and British groups were not significantly different. The Australian patients who had reactions showed a higher incidence of allergy, atopy, asthma and previous adverse reactions than the general population. The incidence was higher in females than males. Although the incidence is higher in the group of patients who reacted, the incidence is not sufficiently great to make pretreatment of patients with a history of allergy or atopy a reasonable prophylactic manoeuvre.
It may be possible to reduce the incidence of severe anaphylactoid reactions to anaesthetic drugs if an at-risk population could be identified and appropriate measures taken prior to induction. Both the previous administration of an anaesthetic' and a past history of allergy or atopy have been said to predispose to anaesthetic reactions in a British population. 2 ,3 Clarke, Fee and Dundee have suggested that when a history of allergy or atopy occurs the patient should not be given the same anaesthetic twice, especially in the case of alfathesin.4 This study was undertaken to determine whether the British and Australian anaesthetic populations are significantly different; whether patients who have reactions to drugs used in anaesthesia have a higher incidence of allergy, atopy and previous exposure than non-reacting patients and whether pretreatment of such patients is practicable.
MATERIALS AND METHODS A. Reacting group
Eighty-five patients referred to one author (M.F.) in the period 1972-1980 were included. Sixteen patients were rejected. Criteria for inclusion was that the anaesthetist concerned considered that the reaction threatened life, and that an anaphylactoid reaction could not be excluded after complement studies, intradermal testing, or challenge. Patients with negative Anaesthesia and Inlensive Care, Vol. VIII, No, 4, November, 1980 intradermal tests were not included if the reaction involved only one organ system and an alternative explanation (overdose, intubation) was more likely. Of the 16 patients excluded 15 have had the same anaesthetic sequence uneventfully and one has had no further anaesthesia.
B. Non-reacting group
Questionnaires were placed in the operating theatres at Royal North Shore Hospital in Sydney to be filled out by anaesthetists. One thousand patients from all surgical specialties were included.
The data from both groups A and B were aggregated using a digital computer.
C. British group
The data for British patients were taken from the published studies of the Belfast group.2,4,5,6,7
The statistical analysis was carried out using Chi squared test. Yates correction was not applied. Because of the difference in numbers of populations weighted means of percentages were used to calculate expected values. P values of greater than 0.95 and less than 0.05 were regarded as significant. Tables 1 to 5 . Table 1 suggests that there is little difference between the British population studied by the Belfast workers and the Australian population surveyed. This Australian population differs from the British in that it is selected from one hospital and may not be truly representative of the Australian anaesthetic population. In both groups the data gathered were based on preoperative interrogation by the anaesthetist, and for reasons of logistics, no attempt was made to confirm these findings by more detailed interrogation. This is justifiable as should the parameters be significant in terms of predicting an at-risk patient, they should be discernible on routine preoperative questioning.
RESULTS
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DISCUSSION
The only significant differences found between the British and Australian nonreacting populations were an increased incidence of allergy and atopy in the same patient for Australian males and a significantly greater number of British patients who had not had a previous anaesthetic. It was interesting to note that the most common allergies documented in both British and Australian groups were identical. The commonest allergies Comparison of Australian patients who reacted to anaesthetic druRs with non-reacting anaesthetic population. 
Comparison of male and female Australian patients who reacted to anaesthetic drugs. stated were penicillin, sticking plaster and iodine. Table 2 showed that patients who had anaphylactoid reactions to anaesthetic drugs had a higher incidence of allergy, atopy, asthma and previous reactions to anaesthesia than a group who had not had reactions. The types of reactions previously experienced were also different. In the non-anaphylactoid group the reactions noted were prolonged block (2), suxamethonium pains (4) and postoperative vomiting in 14. In the anaphylactoid group the reactions were anaphylactoid (6) and postoperative vomiting (2) . Table 3 shows that the incidence of allergy, atopy and asthma in the female reactions was significantly greater than in the male population, and significantly fewer males had not received a previous anaesthetic. Table 4 shows that the incidence of allergy and allergy or atopy is not significantly different from the figures given for British patients who reacted to induction agents. s The Australian group had a significantly higher incidence of atopy. This is probably because the Australian group included patients who reacted to all drugs. A past history of atopy was more common in our patients who reacted to muscle '\lIu(">(hnw and
relaxants than in those who reacted to induction agents. TABLIc 
4
Comparison of British patients who reacted to induction agents and Australian who reacted to any drug used in anaesthesia. Table 5 shows a more detailed analysis of the Australian patients who had anaphylactoid reactions. It can be seen that previous exposure to the drugs implicated in causing the reaction occurs in around 50070 of the patients reacting to induction agents but is uncommon in all the other agents implicated.
We therefore conclude that previous exposure is not significant in the majority of reactions in this series, although it is more common in patients who react to induction agents. As the incidence of previous anaesthesia is not significantly different in reacting and non-reacting patients, it is unlikely that a history of previous anaesthesia will have any value in predicting such reactions. A previous anaphylactoid reaction should be regarded as a serious prognostic finding, occurring in six of 85 reactors, and none of 1000 non-reactors.
Although only 50% of patients who reacted to alfathesin had previous exposure the British experience suggests that a second exposure within a short period is dangerous,4,9 and alfathesin should be avoided for repeated anaesthesia. Clarke, Fee and Dundee 4 have further suggested that in patients with an allergic or atopic history the same anaesthetic should not be given twice, or the interval between administrations kept as long as possible. While this is probably true for alfathesin, Table 5 shows that in 85 reactors previous exposure, and allergy or atopy, was present in only six, and this recommendation does not appear valid for the Australian group.
The higher incidence of allergy, asthma, atopy and previous anaphylactoid reactions AllaeSfhet>/a ancllntensive Care, Vol. VIII .. "'/0. 4, Sovember, 1980 confirms that they are predisposing factors. Pretreatment of these patients could reduce the incidence of anaphylactoid reactions.
Several methods of pretreatment have been suggested. HI and H2 antihistamines should prevent the reactions due to the direct histamine release consequent upon rapid infusion of haemaccel. 3 However many anaphylactoid reactions involve the release of mediators other than histamine, and activated complement fractions may act directly as well as by mediator release. ID In the case of dextrans fatal reactions may be associated 'with complement C3 activation without rise in plasma histamine. 3 ,12 Disodium cromoglycate has been suggested as useful in prophylaxis 3 ,I2 but would probably only be effective in IgE mediated reactions and has not been studied.
A combination of high dose steroid and antihistamine has been shown to prevent an anaphylactoid reaction in an anaesthetist who was allergic to propanidid. 13 The pretreatment with a 24 hour course of steroids and an antihistamine one hour before exposure prevented second reactions to contrast media in patients with a past history of a severe reaction 14 although reassurance alone reduces the incidence of reactions to contrast. 15 Sutherland 16 has suggested that pretreatment with steroids, antihistamines and adrenaline has virtually eliminated anaphylaxis due to antivenoms.
High dose steroids inhibit complement activation also and the most logical form of pretreatment in preoperative patients is a combination of steroid and antihistamine.
Who should receive such treatment? A history of allergy or atopy occurred in 19% of the Australian surgical population in this study and in 46% of the reacting population. The rate of life-threatening anaphylactoid reactions in Australia is of the order of one in 5000 general anaesthetics. 17 Thus if in 100,000 preanaesthetic patients all patients with a history of allergy or atopy were pretreated, 19,000 would receive treatment. Nine reactions may be prevented and 11 still occur.
It would seem a far more effective prophylactic manoeuvre to eliminate the use of alfathesin which is used as induction agent in 24% of British anaesthetics and has a reaction rate of 1 :430 to 1: 11 ,000. 'Cross sensitivity may occur between gallamine and suxamethonium and alcuronium and d-tubocurarine (8) Use of a test dose has been shown to be ineffective and dangerous with contrast media 18 and ineffective in detecting reactions to alfathesin. 19 In patients with a history of a previous life-threatening anaphylactoid reaction to a drug used in general anaesthesia the drug implicated should be determined and that and similar drugs should be avoided if possible. When the drug implicated is not definitely known pretreatment with steroids and antihistamines should be employed. The pretreatment of patients at-risk due to allergy or atopy does not appear a reasonable proposition.
